LME three-month tin price rose by more than 10% to US $27100 / ton.

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

Biotech Yanyang Bio Raises CNY 100 Mn in Series A Financing Round

Biotech Yanyang Bio, focusing on the research and development of innovative drugs based on human active bacteria, will continue to promote its R&D and commercialization capacity with the fresh proceeds.

Biopharma Bivision Earns Nearly CNY 100 million in Angel Financing Round

Bivision, a biopharma company focusing on the development of visual targeted radionuclide therapy which integrates diagnosis with treatment, will continue to develop innovative targeted radionuclide drugs with the fresh proceeds.

15 Companies to Watch in July 2022 - Healthcare

Editor's note: We at EqualOcean tracked the major funding rounds or industry events that took place in China's healthcare space in July 2022. And the following is a list of deals that we have selected for you, based on a number of criteria including the funding amount, the financial backers, and the segments in which the startups operate.

Grand Pharmaceutical Group Invest EUR 15 Mn in Dutch MedTech Xeltis

​Founded in 2006, Grand Pharmaceutical has developed a polymer-based restorative device for cardiovascular treatment. The restorative devices comprise heart valves and small diameter blood vessels for coronary artery bypass graft (CABG) surgery and for hemodialysis vascular access.